Jiazhuo Liu

Nivolumab treatment of relapsed/refractory Epstein-Barr virus–associated hemophagocytic lymphohistiocytosis in adults

Pengpeng Liu, Xiangyu Pan, Chong Chen et al. · Blood · 2020 · 134 citations

Medicine, Immunology, Oncology +12

SECTM1-based CAR T cells enriched with CD7-low/negative subsets exhibit efficacy in CD7-positive malignancies

Wenwen Wei, Haiyan Ma, Dong Yang et al. · Blood Advances · 2023 · 28 citations · Full text

Life Sciences, Immunology, Oncology +17

A new conditioning regimen with chidamide, cladribine, gemcitabine and busulfan significantly improve the outcome of high‐risk or relapsed/refractory <scp>non‐Hodgkin</scp>'s lymphomas

Jie Ji, Zhigang Liu, Pu Kuang et al. · International Journal of Cancer · 2021 · 22 citations

Medicine, Oncology, Pharmacology +16

Intensive induction chemotherapy with regimen containing intermediate dose cytarabine in the treatment of de novo acute myeloid leukemia

Jiazhuo Liu, Yingchang Mi, Mingwei Fu et al. · American Journal of Hematology · 2009 · 21 citations · Full text

Medicine, Oncology, Pharmacology +13

Myelomonocytic and monocytic acute myeloid leukemia demonstrate comparable poor outcomes with venetoclax-based treatment: a monocentric real-world study

Lei Zhao, Jinjun Yang, Mengran Chen et al. · Annals of Hematology · 2024 · 17 citations

Medicine, Hematology, Oncology +9